Ott, Katja <br/><br/>
DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.  [electronic resource] 

 -  Annals of surgical oncology  Sep 2011 
 - 2688-98 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1534-4681 
<br/><br/><label>Standard No.: </label>10.1245/s10434-011-1601-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cisplatin--administration & dosage<br/>Clinical Trials, Phase II as Topic<br/>DNA Repair--genetics<br/>DNA, Neoplasm--genetics<br/>Esophageal Neoplasms--drug therapy<br/>Female<br/>Fluorouracil--administration & dosage<br/>Follow-Up Studies<br/>Genotype<br/>Humans<br/>Male<br/>Methylenetetrahydrofolate Reductase (NADPH2)--genetics<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasm Staging<br/>Polymerase Chain Reaction<br/>Polymorphism, Genetic--genetics<br/>Prospective Studies<br/>Retrospective Studies<br/>Stomach Neoplasms--drug therapy<br/>Survival Rate<br/>Treatment Outcome